FIELD: medicine, ophthalmology.
SUBSTANCE: the present innovation deals with treating different forms of amblyopia. It is necessary to carry out medicinal correction of neurological disorders in a patient that includes vasoactive preparations, venotonics, nootropes and metabolics. One should conduct electrophoresis of spasmolytics onto area of jugular vertebral department at current power being 0.5-1.0 mA/sq. cm per 10 min, daily. Simultaneously,, it is necessary to carry out argon-laser stimulation of retinal central area and projection of papillo-macular bundle, about 150-200 impulses/seance, radiation power being 0.05 W, radiation diameter of 1000 mc, exposure time of 0.01 sec, wave length being 498-514 nm every other day. Therapy course lasts for 10 d. The innovation enables to achieve positive dynamics in treating severe forms of amblyopia, restore visual function and obtain correction of neurological disorders.
EFFECT: higher efficiency of therapy.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING REFRACTION AMBLYOPIA | 1998 |
|
RU2161939C2 |
METHOD FOR TREATING THE CASES OF REFRACTION AMBLYOPIA | 2001 |
|
RU2201729C1 |
METHOD FOR TREATING ANISOMETROPIC REFRACTION AMBLYOPIA | 1999 |
|
RU2150253C1 |
METHOD FOR TREATING THE CASES OF REFRACTION AMBLYOPIA | 2004 |
|
RU2275911C1 |
METHOD OF TREATING EARLY MANIFESTATIONS OF AGE-RELATED MACULAR RETINAL DEGENERATION | 2014 |
|
RU2549673C1 |
METHOD OF FORMING CENTRAL VISUAL FIXATION AND INCREASING RETINAL PHOTOSENSITIVITY IN CHILDREN WITH AMBLYOPIA WITH UNSTABLE CENTRAL FIXATION AND NONCENTRAL FIXATION | 2020 |
|
RU2741696C1 |
METHOD OF TREATING DEGENERATIVE AND DYSTROPHIC RETINAL DISEASES | 2012 |
|
RU2495669C1 |
METHOD FOR TREATING ANTERIOR EYE SEGMENT | 1998 |
|
RU2155565C2 |
METHOD FOR INCREASING OPTIC FUNCTIONS IN CHILDREN WITH INBORN OPTIC NYSTAGMUS | 2005 |
|
RU2295280C1 |
METHOD FOR EYE REFRACTIVE DISEASE TREATMENT | 2006 |
|
RU2336850C2 |
Authors
Dates
2006-08-10—Published
2004-10-12—Filed